DoD Bone Marrow Failure, Idea Development Award
The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases.
This award mechanism is designed to support new ideas.
Proposed research studies should have a high probability of revealing new avenues of investigation.
The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.
Hypothesis-driven correlative studies associated with clinical trials that meet the innovative intent of this award mechanism are encouraged.
An application that proposes a correlative study should be associated with a clinical trial(s), and the proposed study should facilitate the generation of new hypotheses or advance the understanding of disease biology, treatment mechanisms, or other innovative and impactful outcomes.
Funding to conduct the clinical trial itself is outside the scope of this funding opportunity.This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs).
ECIs will be assessed using different criteria for personnel during the review process (refer to Section II.E.
1. a, Peer Review).
Independent of career level, personnel on the proposed team should have a strong background in BMF disease research.
This award mechanism is designed to support new ideas.
Proposed research studies should have a high probability of revealing new avenues of investigation.
The research project should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research approach.
Hypothesis-driven correlative studies associated with clinical trials that meet the innovative intent of this award mechanism are encouraged.
An application that proposes a correlative study should be associated with a clinical trial(s), and the proposed study should facilitate the generation of new hypotheses or advance the understanding of disease biology, treatment mechanisms, or other innovative and impactful outcomes.
Funding to conduct the clinical trial itself is outside the scope of this funding opportunity.This funding opportunity is open to Established Investigators (EIs) and Early-Career Investigators (ECIs).
ECIs will be assessed using different criteria for personnel during the review process (refer to Section II.E.
1. a, Peer Review).
Independent of career level, personnel on the proposed team should have a strong background in BMF disease research.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
https://grants.hrsa.gov/webExternal/SFO.asp?ID=90E776E8-4C99-430F-B46C-31A440AEAB25
Additional Information of Eligibility:
All applicants, including current grantees, must document Medicaid provider status.
Applicants may document formal agreements with Medicaid providers for provision of all services covered under the Medicaid State plan.
This requirement may be waived for free clinics that do not impose a charge for health services and do not accept reimbursement from Medicaid, Medicare, or private insurance.
All applicants, including current grantees, must document that they are fully licensed to provide clinical services, as required by their State and/or local jurisdiction.
Medicaid provider status and licensure must be in place prior to submitting an application.
Full Opportunity Web Address:
https://grants.hrsa.gov/webExternal/SFO.asp?ID=90E776E8-4C99-430F-B46C-31A440AEAB25
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2024-06-07
Application Due Date:
Archive Date:
2024-11-08
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
